Results of Operations and Financial Condition” and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Chief Financial Officer — John E. Gallagher: The company hired a new CFO from an external source.

Entry into a Material Definitive Agreement. On June 3, 2026, CONMED Corporation, a Delaware corporation (“ CONMED ”), entered into separate, privately negotiated purchase agreements (the “ Purchase Agreements ”) with certain holders of its 2.25% Convertible Senior Notes due 2027 (the “ Notes ”). Under the terms of the Purchase Agreements, the Company agreed to purchase approximately $645.2 million aggregate principal amount of Notes from the holders thereof for approximately $637.2 million in…

Creation of a Direct Financial Obligations or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The description of the First Amendment set forth in

Entry into a Material Definitive Agreement. On May 27, 2026, CONMED Corporation, a Delaware corporation (“ CONMED ”) entered into the First Omnibus Amendment and Increased Facility Activation Notice (the “ First Amendment ”), among CONMED and its subsidiary Linvatec Nederland B.V., a Netherlands private limited company ( besloten vennootschap ), as borrowers; certain of CONMED’s other subsidiaries, as guarantors; the several banks and other financial institutions party thereto, as lenders; an…

Director — Celine Martin and Jeff Mirviss: The Board of Directors increased its size and appointed two new non-employee directors.

Results of Operations and Financial Condition” and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Interim Principal Financial Officer — Andrew Moller: Andrew Moller was appointed as the Interim Principal Financial Officer.

Results of Operations and Financial Condition” and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

CFO — Todd Garner: The CFO is being terminated from his role with a transition period, representing the loss of a senior executive.

Results of Operations and Financial Condition” and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Director — Kim Kelderman: The filing discloses the appointment of a new independent director to the board, which is a routine governance event and not a departure of a senior executive.

Other Events CONMED Corporation announced its Board of Directors declared a quarterly cash dividend of $0.20 per share on August 7, 2025, payable on October 3, 2025, to all shareholders of record as of September 15, 2025. Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 7, 2025 CONMED CORPORATION (Registrant) By: /s/ Todd W. Garner Name:…

Results of Operations and Financial Condition” and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Director — Martha Aronson: The resignation of an independent director is a standard board turnover event with low materiality and no indication of conflict or operational impact.

Entry into a Material Definitive Agreement. On June 10, 2025, CONMED Corporation, a Delaware corporation (“ CONMED ”), and its subsidiary Linvatec Nederland B.V., a Netherlands private limited company ( besloten vennootschap ), entered into the Eighth Amended and Restated Credit Agreement (the “ Credit Agreement ” ), among CONMED, the Foreign Subsidiary Borrowers (as defined therein) from time to time parties thereto, the several banks and other financial institutions or entities from time to…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant The information set forth under

Other Events. CONMED Corporation announced its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 19, 2025, payable on July 3, 2025, to all shareholders of record as of June 13, 2025.

Director: The filing reports the results of the annual meeting of stockholders, which typically involves the routine election of directors.

Results of Operations and Financial Condition” and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Vice President, Corporate Controller — Andrew Moller: The filing discloses the external hire of a new Vice President, Corporate Controller and Principal Accounting Officer, replacing an interim officer, which is a significant staffing change but not a departure of a sitting senior executive.

Director — Mark Kaye: The filing discloses the appointment of a new director to an expanded board, which is a routine governance event and not a departure of a senior executive.

Other Events CONMED Corporation announced its Board of Directors declared a quarterly cash dividend of $0.20 per share on February 24, 2025, payable on April 4, 2025, to all shareholders of record as of March 14, 2025.

Results of Operations and Financial Condition” and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Other Events CONMED Corporation announced its Board of Directors declared a quarterly cash dividend of $0.20 per share on December 9, 2024, payable on January 3, 2025, to all shareholders of record as of December 20, 2024. Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 9, 2024 CONMED CORPORATION (Registrant) By: /s/ Todd W. Garner Na…